This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Company Filing History:
1 out of 834,453 Years Active: 2001
Title: Léna Edelman: Innovator in Monoclonal Antibody Development
Introduction
Léna Edelman is a notable inventor based in Boulogne, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical research and therapeutic applications.
Latest Patents
Edelman holds a patent for the "Monoclonal recombinant anti-rhesus D (D7C2) antibody." This invention involves the cloning of DNA fragments that code for the light chain or heavy chain variable domain of the D7C2 monoclonal antibody within a baculovirus. The patent also covers the expression of these DNA fragments in insect host cells, the resulting anti-rhesus D recombinant monoclonal antibody, and its various uses. He has 1 patent to his name.
Career Highlights
Throughout his career, Léna Edelman has focused on advancing the understanding and application of monoclonal antibodies. His innovative approaches have contributed to the development of new therapeutic options in the medical field.
Collaborations
Edelman has worked alongside notable colleagues such as Hassan Chaabihi and Michel Kaczorek. Their collaborative efforts have furthered research and development in the biotechnology sector.
Conclusion
Léna Edelman's contributions to the field of monoclonal antibodies exemplify the impact of innovation in biotechnology. His work continues to influence medical research and therapeutic advancements.